Padmaja brings over a decade of experience leading the design and optimization of data infrastructure in the demanding semiconductor industry.

Co-authored by Shamnad Mohamed Shaffi of Amazon Web Services, Sunish Vengathattil of Clarivate Analytics, and Jinal Mehta of Amazon, the study explores how a cutting-edge data lakehouse architecture ...

In an era where data is a strategic asset, organizations often falter not because they lack data—but because their architecture doesn’t scale with their needs. Leaders must design data ecosystems that ...

Generative artificial intelligence disrupted the enterprise in 2023 and is now a must-have consideration in 2024 plans. With this in mind, technical professionals must strive to enhance and modernize ...

AI and data are feeding each other — build the right strategy and you’ll unlock smarter decisions, better agility and a real ...

Data integration is a leading priority for enterprise executives, with 82% of senior executives considering scaling AI a top priority. However, this ambition is frustrated by the longstanding practice ...

Does your company need a data architect? Your email has been sent Why the Database Market Keeps Growing Bigger and Stronger Top 7 Power BI Alternatives and Competitors What Is Data Literacy, and Why ...

The easiest way to think about an open data architecture is that it’s the opposite of a vendor-locked-in, closed-system environment. A system designed with open data architectural principles supports ...

In this article, we explore how AI agents are reshaping software development and the impact they have on a developer’s workflow. We introduce a practical approach to staying in control while working ...

The emerging data mesh architecture has the potential to keep AI and analytics projects moving forward even as data storage and processing continues to disperse far and wide. One independent backer of ...

The reliance of the pharmaceutical industry on data is fairly high for planning clinical trials, managing resources, and bringing new drugs to market. Yet one of its biggest challenges remains the ...